Data / Form D filings / Verseon Corp
Verseon Corp: Form D filings
Verseon Corp, a pharmaceuticals company in Fremont, CA, filed 7 Form D notices with the SEC between 2015 and 2019. The latest, on April 24, 2019, reports $101,400 sold of a $101,400 offering to 1 investor.
Find out what Verseon Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 47071 Bayside Parkway, Fremont, CA, 94538
- Phone
- (510) 225-9000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1348948
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 24, 2019 | New notice | $101,400 | $101,400 | $0 | 1 | Mar 18, 2019 | sec.gov |
| May 15, 2015 | New notice | $11,808,858 | $11,808,858 | $0 | 5 | Sep 16, 2009 | sec.gov |
| May 15, 2015 | New notice | $451,000 | $451,000 | $0 | 10 | Nov 10, 2014 | sec.gov |
| May 15, 2015 | New notice | $69,827 | $69,827 | $0 | 5 | Jun 30, 2011 | sec.gov |
| May 15, 2015 | New notice | $259,573 | $259,573 | $0 | 13 | Sep 30, 2010 | sec.gov |
| May 15, 2015 | New notice | $6,488,600 | $6,488,600 | $0 | 22 | Oct 31, 2005 | sec.gov |
| May 14, 2015 | New notice | $5,832,264 | $5,832,264 | $0 | 28 | Feb 20, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas Hecht | Director | |
| Sangtae Kim | Director | |
| Eniko Fodor | Executive Officer, Director | |
| Adityo Prakash | Executive Officer, Director | |
| David Kita | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Apr 22, 2019 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Verseon Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.